BeyondSpring (BYSI) to Present Three Abstracts from PROTECTIVE-2 Phase 3 Trials of Plinabulin at ASCO

Go back to BeyondSpring (BYSI) to Present Three Abstracts from PROTECTIVE-2 Phase 3 Trials of Plinabulin at ASCO
(NASDAQ: BYSI) Delayed: 22.91 +0.40 (1.78%)
Previous Close $22.51    52 Week High
Open $22.63    52 Week Low
Day High $23.02    P/E N/A 
Day Low $21.74    EPS
Volume 1,180,119